Related Experiment Video

Updated: May 19, 2026

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
15:04

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Published on: January 19, 2019

Anticancer siRNA delivery by new anticancer molecule: a novel combination strategy for cancer cell killing

Prathap Reddy Muktapuram1, Rishi Kumar Gara, Komal Sharma

  • 1Division of Pharmaceutics, CSIR-Central Drug Research Institute, Chattar Manzil Palace, 1-M.G. Marg, Lucknow 226001, India.

European Journal of Medicinal Chemistry
|August 29, 2012
PubMed

Insights

Researchers developed a novel bifunctional molecule that selectively kills cancer cells and delivers small interfering RNA (siRNA) for enhanced anticancer therapy. This dual-action agent shows significant potential in cancer treatment by combining direct antiproliferative effects with targeted gene silencing.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Drug Discovery

Background:

  • Developing targeted cancer therapies remains a critical challenge.
  • Novel drug delivery systems are needed to enhance therapeutic efficacy and reduce side effects.
  • Bifunctional molecules offer a promising strategy for combined therapeutic action.

Purpose of the Study:

  • To synthesize and characterize a novel bifunctional molecule with both selective antiproliferative activity and siRNA transfection capabilities.
  • To evaluate the in vitro anticancer efficacy of the developed molecule.
  • To assess the synergistic effect of the molecule when used in combination with siRNA for cancer treatment.

Main Methods:

  • Synthesis of a series of cationic lipo-benzamides.
  • In vitro screening of anticancer activity against various cancer and non-cancer cell lines.
  • Cell cycle analysis to determine the mechanism of antiproliferative action.
  • Evaluation of siRNA delivery efficiency in vitro.
  • Assessment of combined therapeutic effects of the molecule and survivin-targeting siRNA.

Main Results:

  • A specific molecule (C10M) demonstrated selective inhibition of cancer cell proliferation by arresting the cell cycle in the G1 phase, with no significant effect on non-cancerous cells.
  • C10M effectively mediated in vitro siRNA delivery.
  • The combination of C10M and survivin-targeting siRNA showed a significantly superior anticancer effect compared to the agent alone (p < 0.05).

Conclusions:

  • This study reports the first dual-purpose molecule with intrinsic anticancer activity and siRNA delivery functionality.
  • The developed bifunctional molecule (C10M) offers a promising new platform for targeted cancer therapy.
  • The synergistic effect observed highlights the potential of combining direct cytotoxic action with gene silencing for enhanced cancer treatment.

More Related Videos

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells07:23

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells

Published on: May 30, 2025

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?14:20

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...